Nanoparticle formulation CPI-300
Term · Oncology and biomedicine · MLC-T-ONC-015423
A nanoparticle-based formulation composed of a nanoscale coordination polymer (NCP) complex containing two as of yet undisclosed anti-tumor agents, with potential antineoplastic activities. Upon intravenous administration, nanoparticle formulation CPI-300 delivers the anti-tumor agents to tumor cells, which may lead, through as of yet undisclosed mechanism of actions (MoAs), to specific tumor cell killing and inhibition of proliferation of tumor cells.
| Identifier | MLC-T-ONC-015423 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | nanoscale coordination polymer-based formulation CPI-300; NCP platform-based CPI-300 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015423",
"term": "Nanoparticle formulation CPI-300",
"field": "Oncology and biomedicine",
"definition": "A nanoparticle-based formulation composed of a nanoscale coordination polymer (NCP) complex containing two as of yet undisclosed anti-tumor agents, with potential antineoplastic activities. Upon intravenous administration, nanoparticle formulation CPI-300 delivers the anti-tumor agents to tumor cells, which may lead, through as of yet undisclosed mechanism of actions (MoAs), to specific tumor cell killing and inhibition of proliferation of tumor cells.",
"synonyms": [
"nanoscale coordination polymer-based formulation CPI-300",
"NCP platform-based CPI-300"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/nanoparticle-formulation-cpi-300/"
}
Record 11,575 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.